Rujukan Glukosa 6-fosfatase

  1. 1 2 3 "The catalytic center of glucose-6-phosphatase. HIS176 is the nucleophile forming the phosphohistidine-enzyme intermediate during catalysis". The Journal of Biological Chemistry. 277 (36): 32837–42. September 2002. doi:10.1074/jbc.M201853200. PMID 12093795.
  2. ↑ Nordlie R, dll. (1985). The Enzymes of biological membranes, 2nd edition. New York: Plenum Press. m/s. 349–398. ISBN 0-306-41453-8.
  3. ↑ "Glucose-6-phosphatase catalytic subunit gene family". The Journal of Biological Chemistry. 284 (43): 29241–5. October 2009. doi:10.1074/jbc.R109.025544. PMC 2785553. PMID 19700406.
  4. 1 2 3 4 "Histidine 167 is the phosphate acceptor in glucose-6-phosphatase-β forming a phosphohistidine enzyme intermediate during catalysis". The Journal of Biological Chemistry. 279 (13): 12479–83. March 2004. doi:10.1074/jbc.M313271200. PMID 14718531.
  5. ↑ "In islet-specific glucose-6-phosphatase-related protein, the β cell antigenic sequence that is targeted in diabetes is not responsible for the loss of phosphohydrolase activity". Diabetologia. 48 (9): 1851–9. September 2005. doi:10.1007/s00125-005-1848-6. PMID 16012821.
  6. 1 2 3 4 5 6 "The glucose-6-phosphatase system". The Biochemical Journal. 362 (Pt 3): 513–32. March 2002. doi:10.1042/0264-6021:3620513. PMC 1222414. PMID 11879177.
  7. ↑ "Transmembrane topology of glucose-6-phosphatase". The Journal of Biological Chemistry. 273 (11): 6144–8. March 1998. doi:10.1074/jbc.273.11.6144. PMID 9497333.
  8. ↑ Surholt, B; Newsholme, EA (15 September 1981). "Maximum activities and properties of glucose 6-phosphatase in muscles from vertebrates and invertebrates". The Biochemical Journal. 198 (3): 621–9. doi:10.1042/bj1980621. PMC 1163310. PMID 6275855.
  9. ↑ "Glycogen storage disease type Ia in Argentina: two novel glucose-6-phosphatase mutations affecting protein stability". Molecular Genetics and Metabolism. 83 (3): 276–9. November 2004. doi:10.1016/j.ymgme.2004.06.010. PMID 15542400.
  10. ↑ "Glycogen storage disease type I and glucose-6-phosphatase-β deficiency: etiology and therapy". Nature Reviews. Endocrinology. 6 (12): 676–88. December 2010. doi:10.1038/nrendo.2010.189. PMC 4178929. PMID 20975743.
  11. 1 2 3 "Lack of glucose recycling between endoplasmic reticulum and cytoplasm underlies cellular dysfunction in glucose-6-phosphatase-β-deficient neutrophils in a congenital neutropenia syndrome". Blood. 116 (15): 2783–92. October 2010. doi:10.1182/blood-2009-12-258491. PMC 2974586. PMID 20498302.
  12. ↑ Stryer, Lubert; Berg, Jeremy Mark; Tymoczko, John L. (2007). Biochemistry. San Francisco: W.H. Freeman. ISBN 978-0-7167-8724-2.
  13. ↑ "Glycogen Storage Disease Type I". 1993. PMID 20301489. Cite journal requires |journal= (bantuan)
  14. 1 2 "Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex". Current Molecular Medicine. 2 (2): 121–43. March 2002. doi:10.2174/1566524024605798. PMID 11949931.
  15. 1 2 "Glucose-6-phosphatase deficiency". Orphanet Journal of Rare Diseases. 6: 27. 2011. doi:10.1186/1750-1172-6-27. PMC 3118311. PMID 21599942.
  16. ↑ "G-CSF improves murine G6PC3-deficient neutrophil function by modulating apoptosis and energy homeostasis". Blood. 117 (14): 3881–92. April 2011. doi:10.1182/blood-2010-08-302059. PMC 3083300. PMID 21292774.
  17. ↑ "A syndrome with congenital neutropenia and mutations in G6PC3". The New England Journal of Medicine. 360 (1): 32–43. Jan 2009. doi:10.1056/NEJMoa0805051. PMC 2778311. PMID 19118303.
  18. 1 2 "G6PC3 mutations are associated with a major defect of glycosylation: a novel mechanism for neutrophil dysfunction". Glycobiology. 21 (7): 914–24. July 2011. doi:10.1093/glycob/cwr023. PMC 3110488. PMID 21385794.
  19. ↑ "Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non—insulin-dependent diabetes mellitus - Metabolism - Clinical and Experimental". www.metabolismjournal.com. Dicapai pada 2015-06-16.
  20. ↑ Shehzad, Saima (2013-01-01). "The potential effect of vanadium compounds on glucose-6-phosphatase". Bioscience Horizons. 6: hzt002. doi:10.1093/biohorizons/hzt002. ISSN 1754-7431.